Engineering Anisotropic Meniscus: Zonal Functionality and Spatiotemporal Drug Delivery

dc.contributor.affiliationUniversidade de Santiago de Compostela. Centro de Investigación en Medicina Molecular e Enfermidades Crónicasgl
dc.contributor.affiliationUniversidade de Santiago de Compostela. Departamento de Farmacoloxía, Farmacia e Tecnoloxía Farmacéuticagl
dc.contributor.authorAbbadessa, Anna
dc.contributor.authorCrecente Campo, José
dc.contributor.authorAlonso Fernández, María José
dc.date.accessioned2020-11-02T13:25:26Z
dc.date.available2021-08-26T01:00:09Z
dc.date.issued2020
dc.descriptionThe authors acknowledge the original source of publication. Final publication is available from Mary Ann Liebert, Inc.: http://dx.doi.org/10.1089/ten.teb.2020.0096
dc.description.abstractHuman meniscus is a fibrocartilaginous structure that is crucial for an adequate performance of the human knee joint. Degeneration of the meniscus is often followed by partial or total meniscectomy, which enhances the risk of developing knee osteoarthritis. The lack of a satisfactory treatment for this condition has triggered a major interest in drug delivery (DD) and tissue engineering (TE) strategies intended to restore a bioactive and fully functional meniscal tissue. The aim of this review is to critically discuss the most relevant studies on spatiotemporal DD and TE, aiming for a multizonal meniscal reconstruction. Indeed, the development of meniscal tissue implants should involve a provision for adequate active molecules and scaffold features that take into account the anisotropic ultrastructure of human meniscus. This zonal differentiation is reflected in the meniscus biochemical composition, collagen fiber arrangement, and cell distribution. In this sense, it is expected that a proper combination of advanced DD and zonal TE strategies will play a key role in the future trends in meniscus regenerationgl
dc.description.peerreviewedSIgl
dc.description.sponsorshipThis project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 814444 (MEFISTO); and from Xunta de Galicia’s Grupos de referencia competitiva (grant number ED431C 2017/09)gl
dc.identifier.doi10.1089/ten.teb.2020.0096
dc.identifier.essn1937-3376
dc.identifier.issn1937-3368
dc.identifier.urihttp://hdl.handle.net/10347/23531
dc.language.isoenggl
dc.publisherMary Ann Liebertgl
dc.relation.isversionofhttp://hdl.handle.net/10347/23900
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/H2020/814444
dc.relation.publisherversionhttps://doi.org/10.1089/ten.teb.2020.0096gl
dc.rightsCopyright 2020, Mary Ann Liebert, Inc., publishers.gl
dc.rights.accessRightsopen accessgl
dc.subjectMeniscusgl
dc.subjectDrug deliverygl
dc.subjectGrowth factorsgl
dc.subjectZonal reconstructiongl
dc.subjectTissue engineeringgl
dc.subjectAnisotropic tissue regenerationgl
dc.titleEngineering Anisotropic Meniscus: Zonal Functionality and Spatiotemporal Drug Deliverygl
dc.typejournal articlegl
dc.type.hasVersionAMgl
dspace.entity.typePublication
relation.isAuthorOfPublication9bd225c2-5049-46e6-9930-635ebd6da303
relation.isAuthorOfPublication7bcdc357-e1b8-4198-b799-86057649f479
relation.isAuthorOfPublication.latestForDiscovery9bd225c2-5049-46e6-9930-635ebd6da303

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2020_tissueengineeringbrev_abbadessa_engineering.pdf
Size:
1.35 MB
Format:
Adobe Portable Document Format
Description: